| |
Many expecting parents already know that banking their newborn’s cord blood stem cells is a good idea that may one day save the life of a family member. In fact, cord blood stem cell transplants have been successfully performed in more than 10,000 patients with some 80 known diseases, including leukemia, lymphoma, and immune system disorders.
Many expecting parents also know that cord blood stem cells, like the stem cells found in bone marrow, are non-controversial and free from the political and ethical debate surrounding other types of stem cells. However, with so many cord blood banks to choose from, how do expecting parents find the best cord blood bank for them that will ensure the best lifesaving treatment options for their family’s future health needs?
With this concern and the awareness that soon-to-be parents want maximum peace of mind for their families, LifebankUSA, in collaboration with its parent Celgene, a multinational biopharmaceutical company committed to improving the lives of patients worldwide, started exploring other rich sources of stem cells with the understanding that patients with access to more stem cells would also have access to improved lifesaving treatments. This research led to the breakthrough of finding that placenta-derived stem cells, which have the potential to become different types of cells, could be isolated from the placenta with a proprietary technology so that they would be available for potential lifesaving treatment applications.
Today LifebankUSA offers a service, known by the medical community as Placenta-Cord banking, to bank stem cells derived from the placenta in addition to cord blood stem cells. Only LifebankUSA owns this one-of-a-kind technology to extract these unique types of stem cells from the placenta and preserve them. LifebankUSA provides expecting families more peace of mind by enabling them to bank placenta-derived stem cells in addition to cord blood stem cells. LifebankUSA is the only cord blood bank where expecting parents can bank 2 units of stem cells instead of just 1.This unique combination stores the most stem cells possible. And transplanting more stem cells has been shown to improve transplant success and patient survival in the treatment of potentially life-threatening diseases and conditions.
For the Placenta-Cord banking service, the placenta is simply sent to LifebankUSA using procedures already in place. LifebankUSA then uses its proprietary technology to isolate the cells and bank them on behalf of the client family. More information about this revolutionary service can be found at the LifebankUSA website or by calling 1-877-543-3226.
About LifebankUSA
LifebankUSA, a Celgene company, is one of the largest cord blood banks in the world, and has provided cord blood banking services for tens of thousands of families worldwide. It has released dozens of stem cell units for transplant worldwide. LifebankUSA is also the first bank to allow families to collect and preserve stem cells derived from the placenta, as well as the umbilical cord (Placenta-Cord banking), to rebuild blood and the immune system, including red blood cells, white blood cells, and platelets. What further sets LifebankUSA apart is an active involvement in research along with its parent company Celgene, in a commitment to further the science of stem cells to help ensure a more promising future for both placenta-derived and umbilical cord blood stem cell therapeutics.
Cord blood and human placenta-derived stem cells (HPDSCs) banked with LifebankUSA are intended for autologous use or for allogeneic use in a first-degree or second-degree blood relative. Cord blood and HPDSC infusions are performed to provide hematopoietic progenitor cells for hematopoietic reconstitution.
The chance that a child will use his/her own stored cells during their lifetime is estimated at 1 in 400 (J.J. Nietfeld and F. Verter). These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client’s overall health. Talk with your health care provider. For more information, call 1-877-LIFEBANKUSA (1-877-543-3226) or visit the LifebankUSA website.
|
info[.]lifebankusa.com 
